HC Wainwright Brokers Lower Earnings Estimates for NovoCure
NovoCure Limited (NASDAQ:NVCR – Free Report) – Equities researchers at HC Wainwright dropped their FY2029 earnings per share (EPS) estimates for NovoCure in a research report issued to clients and investors on Thursday, February 27th. HC Wainwright analyst E. Bodnar now forecasts that the medical equipment provider will post earnings per share of $0.23 for […]
